FDA APPROVAL PENDING
Limited Research
Cognitive
IllumiNeuro Protocol
25
Amino acids
Molecular weight
Blend
Type
IllumiNeuro is a cognitive enhancement peptide blend combining four nootropic peptides: PE-22-28 (neuritogenic), Pinealon (pineal bioregulator), NA-Semax Amidate (neuroprotective/cognitive), and NA-Selank Amidate (anxiolytic/cognitive). The standard formulation contains 48mg total (PE-22-28 10mg + Pinealon 10mg + NA-Semax 20mg + NA-Selank 8mg). This blend targets multiple neurological pathways for comprehensive cognitive support, though no clinical studies exist on this specific four-peptide combination.
Each peptide contributes distinct neurological mechanisms: PE-22-28 promotes neurite outgrowth and neural connectivity through sphingosine-1-phosphate receptor modulation; Pinealon is a bioregulator that supports pineal gland function and circadian regulation; NA-Semax Amidate provides BDNF upregulation and neuroprotection; NA-Selank Amidate offers anxiolytic effects through GABA modulation and immune-neuroendocrine regulation. Together, they theoretically address cognitive enhancement, neuroprotection, mood support, and neural regeneration.
Lyophilized: Room temperature. Reconstituted: 2-8°C, use within 4 weeks
Once daily, preferably in the morning for cognitive benefits
100-500 mcg total blend per day
4-8 weeks
Multi-pathway cognitive enhancement
Neuroprotective and neuritogenic effects
Anxiolytic properties from NA-Selank
BDNF upregulation from NA-Semax
Circadian/sleep support from Pinealon
Convenience of single injection
Extended-action amidate forms included
This peptide is still gaining traction in the community.
Four-Peptide Cognitive Enhancement Blend
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of IllumiNeuro Protocol.
25
Amino Acids
IllumiNeuro Protocol
Pro
Pro
Position 1
Glu
Glu
Position 2
Pro
Pro
Position 3
Ile
Ile
Position 4
Asn
Asn
Position 5
Glu
Glu
Position 6
Ala
Ala
Position 7
Leu
Leu
Position 8
Pyl
Pyl
Position 9
Asn
Asn
Position 10
Asn
Asn
Position 11
Ala
Ala
Position 12
Ser
Ser
Position 13
Glu
Glu
Position 14
Met
Met
Position 15
Ala
Ala
Position 16
?
?
Position 17
Asn
Asn
Position 18
Ala
Ala
Position 19
Ser
Ser
Position 20
Glu
Glu
Position 21
Leu
Leu
Position 22
Ala
Ala
Position 23
Asn
Asn
Position 24
Lys
Lys
Position 25
Subcutaneous injection is the standard delivery method. Some users also administer intranasally for more direct CNS effects. Amidate forms (NA-Semax and NA-Selank) have enhanced stability and duration.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Conservative cognitive support | 100 | 1 week range | SubQ or intranasal |
| Standard protocol | 200 | 1 week range | SubQ |
| Enhanced protocol | 400 | 1 week range | SubQ |
Materials needed:
Steps to reconstitute
The IllumiNeuro Protocol Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
2 units
0.025 mL
1 mL
2 mL
3 mL
5 mL
Custom
IllumiNeuro Protocol Composition
(20mg vial)
PE-22-28
10mg (50%)
Pinealon
10mg (50%)
Concentration
20.00
mg/mL
Doses per vial
40
Total blend to inject
0.50
mg
You'll get:
How it works
Select a blend, enter how much water you added, then specify the dose you want of any single component. The calculator figures out how much total blend to inject and shows what you'll get of each peptide.
Recommended Schedule
Once daily, preferably in the morning for cognitive benefits
Supply Duration
This vial provides 40 doses (40-day supply at 250 mcg daily)
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Research suggestions of IllumiNeuro Protocol interactions with other common peptides and substances.
Healing
bpc
Longevity
COMPATIBLE
Different targets; BPC-157 may complement with healing/gut-brain effects.
Cognitive
dih
Longevity
MONITOR
Both highly neuroactive; use caution combining multiple cognitive enhancers.
Longevity
epi
Immunity
COMPATIBLE
Complementary pineal/longevity support; different mechanisms.
Monitor: Be careful when combining IllumiNeuro Protocol with Dihexa.
No clinical trials on four-peptide combination
Bipolar disorder or psychosis (caution with cognitive enhancers)
Pregnancy or breastfeeding
Seizure disorders (theoretical concern)
Severe headaches
Significant mood changes
Allergic reactions
Cognitive impairment instead of enhancement
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
IllumiNeuro Protocol is a limited research compound
IllumiNeuro Protocol
IllumiNeuro Protocol is a limited research compound
PE-22-28 Neuritogenic Effects
PE-22-28 promotes neurite outgrowth through S1P receptor modulation.
n.d.
NA-Semax Amidate Cognitive Enhancement
Enhanced stability amidate form of Semax with BDNF upregulation and neuroprotective effects.
n.d.
NA-Selank Amidate Anxiolytic Properties
Selank demonstrates anxiolytic effects through GABA modulation and immune-neuroendocrine regulation.
n.d.
Pinealon Bioregulator
Pinealon (EDR tripeptide) supports pineal gland function and circadian regulation.
n.d.